GAIA Healthcare was proud to participate as an industry partner and sponsor at the Cardiorenal, Obesity & Metabolic Health Summit (CROMHS 2025), held on 13 September 2025 at the DoubleTree by Hilton in Fujairah, UAE.
This prestigious event brought together leading experts, healthcare professionals, and researchers to discuss the latest innovations and clinical practices in cardiometabolic health, with a strong focus on patient-centered care.
As part of our commitment to advancing cardiovascular health in the region, GAIA Healthcare showcased Combiplax – the first and only dual antiplatelet combination in the UAE, formulated with Clopidogrel and Acetylsalicylic Acid. Our booth served as a platform to engage with physicians and healthcare practitioners, highlighting how Combiplax is shaping new standards in stroke, heart attack, and cardiovascular disease prevention.
Throughout the summit, our team had the opportunity to connect with medical professionals, exchange insights, and reinforce GAIA’s mission:
Delivering innovative healthcare solutions that truly matter.
We thank the CROMHS 2025 organizers for providing this platform and look forward to contributing to future initiatives that drive progress in cardiovascular and metabolic health across the GCC and beyond.
